In April 2026, the FDA published a formal proposal in the Federal Register to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period open through June 2026
We've been serving families ever since
GLP-1: oportunidad estratgica para la farmacia Los GLP-1 llegaron para quedarse en el manejo de diabetes tipo 2 y obesidad en perfiles seleccionados, y la farmacia puede convertir esta tendencia meditica en una oportunidad estratgica, combinando formacin, protocolos claros y gestin responsable
Influence of Endurance Exercise Training and Sex on Intramyocellular Lipid and Mitochondrial Ultrastructure, Substrate Use, and Mitochondrial Enzyme Activity
290,291,292 Accumulating macrophages release cytokines and chemokines, including IL-1, IL-6, chemokine ligand 2 (CCL2), and TNF-, intensifying the inflammatory environment and aggravating nerve damage
Regulatory status Kybella received FDA approval in 2015 after extensive clinical trials